Open an Account
search icon
3
NOTIFICATIONS
Best Algo trading app in India
Bigul

SEQUENT SCIENTIFIC LTD. - 512529 - Submission Of Certificate From A Practicing Company Secretary Under Regulation 40(9) Of Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015

 We hereby submit certificate as received from a Practicing Company Secretary under Regulation 40(9) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 for the year ended March 31, 2023. Kindly take the same on record.
14-04-2023
Bigul

SEQUENT SCIENTIFIC LTD. - 512529 - Submission Under Regulation 7(3) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

 Pursuant to Regulation 7(3) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby submit the Compliance Certificate jointly executed by the authorized representative of our share transfer agent viz. KFIN Technologies Limited and the Compliance Officer of Sequent Scientific Limited for the year ended March 31, 2023.
06-04-2023
Bigul

SEQUENT SCIENTIFIC LTD. - 512529 - Closure of Trading Window

 Sequent Scientific Limited pursuant to the provisions of Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 read with Company''s Code of Conduct for Prohibition of Insider Trading, the Trading Window for all Connected Persons/Designated Persons and their immediate relatives to deal in the securities of the Company shall remain closed from Saturday, April 01, 2023 till 48 hours after the declaration of Audited Financial Results of the Company for the quarter and year ending on March 31, 2023.
30-03-2023

Know your stock | Is there a glimmer of hope for SeQuent Scientific?

 The stock has witnessed a consistent decline since testing its record high in July 2021. Since then, the stock has plunged around 76% on the back of declining profits.
14-03-2023

Why did small cap stock Sequent Scientific hit 20% upper circuit today?

 On Wednesday, in its regulatory filing, Sequent Scientific said, the Company will not acquire Tineta, and the Share Purchase Agreement entered by the Company with Tineta and its Promoters on November 07, 2022 stands terminated.
09-03-2023
Bigul

SEQUENT SCIENTIFIC LTD. - 512529 - Announcement under Regulation 30 (LODR)-Updates on Acquisition

 We refer to our announcement on November 07, 2022, regarding acquisition of 100% stake in Tineta Pharma Private limited ('Tineta') by the Company, it is hereby informed that the transaction contemplated under the Share Purchase Agreement has not been materialized. Therefore, the Company will not acquire Tineta and the Share Purchase Agreement entered by the Company with Tineta and its Promoters on November 07, 2022 stands terminated.
08-03-2023
Bigul

SEQUENT SCIENTIFIC LTD. - 512529 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

 Pursuant to Regulation 30(6) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing herewith the Earnings Call Transcript pertaining to the Unaudited Financial Results of the Company for quarter and nine months ended December 31, 2022.
21-02-2023
Bigul

SEQUENT SCIENTIFIC LTD. - 512529 - Announcement under Regulation 30 (LODR)-Newspaper Publication

 Pursuant to the provision of Regulation 30 and 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed copies of advertisement published on February 16, 2023, in 'Financial Express' and 'Mumbai Lakshadeep' newspaper providing Extracts of Unaudited Financial Results of the Company for the quarter and nine months ended December 31, 2022.
16-02-2023
Bigul

SEQUENT SCIENTIFIC LTD. - 512529 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

 Pursuant to Regulation 30(6) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, the audio recording of the earnings call and earnings presentation made on February 15, 2023, on Unaudited Financial Results (Consolidated and Standalone) of the Company for the quarter and nine months ended December 31, 2022, is available on the Company's website.
15-02-2023
Bigul

SEQUENT SCIENTIFIC LTD. - 512529 - Unaudited Financial Results For The Quarter And Nine Months Ended December 31, 2022

 The Board of Directors at its meeting held today, viz. February 14, 2023, has considered and approved the unaudited standalone and consolidated financial results for the quarter and nine months ended December 31, 2022. A copy of the said results along with the limited review report and , is enclosed. A press release along with the investor presentation issued in this regard, is also enclosed.
14-02-2023
Next Page
Close

Let's Open Free Demat Account